1. Home
  2. ASIX vs RCKT Comparison

ASIX vs RCKT Comparison

Compare ASIX & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AdvanSix Inc.

ASIX

AdvanSix Inc.

HOLD

Current Price

$15.68

Market Cap

460.1M

Sector

Industrials

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$2.28

Market Cap

239.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASIX
RCKT
Founded
2016
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
460.1M
239.3M
IPO Year
2016
2014

Fundamental Metrics

Financial Performance
Metric
ASIX
RCKT
Price
$15.68
$2.28
Analyst Decision
Buy
Buy
Analyst Count
2
14
Target Price
★ $20.00
$8.58
AVG Volume (30 Days)
212.4K
★ 2.2M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
★ 4.08%
N/A
EPS Growth
11.11
★ 26.37
EPS
N/A
★ 0.66
Revenue
★ $1,684,625,000.00
N/A
Revenue This Year
$9.86
N/A
Revenue Next Year
$5.06
$915.60
P/E Ratio
★ N/A
$3.50
Revenue Growth
★ 45.49
N/A
52 Week Low
$14.10
$2.17
52 Week High
$26.73
$5.45

Technical Indicators

Market Signals
Indicator
ASIX
RCKT
Relative Strength Index (RSI) 39.57 37.77
Support Level $15.46 N/A
Resistance Level $16.93 $3.70
Average True Range (ATR) 0.44 0.18
MACD -0.05 0.02
Stochastic Oscillator 30.73 18.70

Price Performance

Historical Comparison
ASIX
RCKT

About ASIX AdvanSix Inc.

AdvanSix Inc is a diversified chemistry company playing a critical role in international supply chains, innovating and delivering essential products for customers across a wide variety of end markets and applications that touch people's lives, including building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, and electronics. The company's key products include Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates. The majority of sales are from Plant Nutrients products. The company operates in the United States and internationally, with the majority of revenue coming from the United States.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: